Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series
- DOI
- 10.1002/hed.27346
- Published
- 2023-03-16
- Container
- Head & Neck
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hed.27346,
title = {Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series},
author = {Tomoya Yokota and Hiroki Yukino and Mihoko Doi and Hisatsugu Ohori},
year = {2023},
journal = {Head \& Neck},
doi = {10.1002/hed.27346},
url = {https://doi.org/10.1002/hed.27346}
}RIS
TY - JOUR TI - Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series AU - Tomoya Yokota AU - Hiroki Yukino AU - Mihoko Doi AU - Hisatsugu Ohori PY - 2023 JO - Head & Neck DO - 10.1002/hed.27346 UR - https://doi.org/10.1002/hed.27346 ER -
APA
Yokota, T., Yukino, H., Doi, M., & Ohori, H. (2023). Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series. Head & Neck. https://doi.org/10.1002/hed.27346
Source records
- crossref · retrieved 2026-09-27T04:24:24.772Z